Relation of Serum Total Cholesterol and Other Factors to Risk of Cerebral Infarction in Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study
スポンサーリンク
概要
- 論文の詳細を見る
Background Risk factors for cerebral infarction have not been well clarified, except for hypertension (HT), and few studies have examined the risk factors in the elderly. Methods and Results Clinical and behavioral risk factors for cerebral infarction were examined in 4,349 Japanese men aged 45-74 years with a serum total cholesterol (TC) concentration of 220mg/dl or greater who participated in the Kyushu Lipid Intervention Study. A total of 81 men developed definite cerebral infarction in a 5-year follow-up period. The Cox proportional hazards model was used with serum TC at baseline and during the follow-up, serum high-density lipoprotem-cholesterol (HDL-C), HT, diabetes mellitus (DM), and other factors as covariates. Serum TC during the follow-up, not at baseline, was positively associated with cerebral infarction, showing a stronger association in the elderly (>65 years old) than in the middle-aged (<65 years old). Statin use was related to a moderate decrease in the risk of cerebral infarction when follow-up TC was not considered, but the decrease was almost nullified after adjustment for follow-up TC. A low concentration of serum HDL-C, diabetes mellitus, hypertension, and angina pectons were each related to an increased risk. No clear association was observed for body mass index, smoking or alcohol use. Conclusions Lowering cholesterol is important in the prevention of cerebral infarction in men with moderate hypercholesterolemia. A low concentration of HDL-C, DM, and HT are independent predictors of cerebral infarction.
- 社団法人日本循環器学会の論文
- 2004-12-20
著者
-
Kono Suminori
Department Of Preventive Medicine Kyushu University Faculty Of Medical Sciences
-
Kono Suminori
Kyushu University Faculty of Medical Sciences
-
SASAKI Jun
Graduate School of Clinical Trial Management, International University of Health and Welfare
-
IWASHITA Mikio
Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences
-
Iwashita Mikio
Kyushu Lipid Intervention Study (KLIS) Group
-
Matsushita Yasuyuki
Kyushu Lipid Intervention Study (KLIS) Group
-
Sasaki Jun
Kyushu Lipid Intervention Study (KLIS) Group
-
Arakawa Kikuo
Kyushu Lipid Intervention Study (KLIS) Group
-
Iwashita Mikio
Department Of Preventive Medicine Kyushu University Faculty Of Medical Sciences
-
Arakawa Kikuo
Kyushu Lipid Intervention Study (klis) Group:the Second Department Of Internal Medicine Fukuoka Univ
-
Sasaki Jun
Graduate School Of Clinical Trial Management International University Of Health And Welfare
-
Matsushita Yasuyuki
Kyushu Lipid Intervention Study (klis) Group:departments Of Postmarketing Surveillance And Regulator
関連論文
- Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin
- Statins : Beneficial or Adverse for Glucose Metabolism
- Relation of Serum Total Cholesterol and Other Factors to Risk of Cerebral Infarction in Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study
- Relation of Serum Total Cholesterol and Other Risk Factors to Risk of Coronary Events in Middle-Aged and Elderly Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study
- Reduction in Serum Total Cholesterol and Risks of Coronary Events and Cerebral Infarction in Japanese Men : The Kyushu Lipid Intervention Study
- Is the reno-protective effect of valsartan dose dependent? A comparative study of 80 and 160mg day^
- 3 Cutpoint for Categorical Lower HDL cholesterol Concentration in Metabolic Syndrome(Clinical definition of metabolic syndrome,Controversy 3 (C-3) (H),Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- 2 Strategy for Treating Hypercholesterolemia from Japanese Evidence(LDL-cholesterol : How Low Should We Go in Japanese Population?, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011) : Digest Version
- Compound Heterozygotes for a Novel Mutation, Apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with Severe Type III Hyperlipoproteinemia and Familial Hypercholesterolemia